Search

everythinglearnresearchcommunity

for

Search:↓

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

The niosomal gel effectively delivers testosterone through the skin with fewer side effects.

Exosome-based treatments may improve skin and hair issues, but more research is needed for safety and effectiveness.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Combining certain treatments, including FOL005, may improve healing of difficult wounds.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Transethosomes improve drug delivery through the skin by overcoming the outer skin layer's barrier.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

Rare earth elements are crucial in medical imaging and cancer treatment.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Erlotinib can cause excessive eyelash growth.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Etretinate treatment changed hair growth patterns in many patients.

A man developed skin issues from cancer medication, which improved with specific treatments.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.